Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DarioHealth (DRIO) Raw Materials (2018 - 2025)

DarioHealth filings provide 8 years of Raw Materials readings, the most recent being $751000.0 for Q4 2025.

  • On a quarterly basis, Raw Materials rose 33.39% to $751000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $751000.0, a 33.39% increase, with the full-year FY2025 number at $751000.0, up 33.39% from a year prior.
  • Raw Materials hit $751000.0 in Q4 2025 for DarioHealth, down from $793000.0 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $1.3 million in Q4 2022 to a low of $438000.0 in Q1 2021.
  • Median Raw Materials over the past 5 years was $888500.0 (2022), compared with a mean of $912650.0.
  • Biggest five-year swings in Raw Materials: soared 119.39% in 2022 and later tumbled 44.53% in 2024.
  • DarioHealth's Raw Materials stood at $714000.0 in 2021, then soared by 88.52% to $1.3 million in 2022, then decreased by 24.59% to $1.0 million in 2023, then tumbled by 44.53% to $563000.0 in 2024, then skyrocketed by 33.39% to $751000.0 in 2025.
  • The last three reported values for Raw Materials were $751000.0 (Q4 2025), $793000.0 (Q3 2025), and $850000.0 (Q2 2025) per Business Quant data.